These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23204604)

  • 21. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women.
    Kugaya A; Epperson CN; Zoghbi S; van Dyck CH; Hou Y; Fujita M; Staley JK; Garg PK; Seibyl JP; Innis RB
    Am J Psychiatry; 2003 Aug; 160(8):1522-4. PubMed ID: 12900319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects.
    Muguruza C; Moreno JL; Umali A; Callado LF; Meana JJ; González-Maeso J
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):852-64. PubMed ID: 23176747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder.
    Frokjaer VG; Mortensen EL; Nielsen FA; Haugbol S; Pinborg LH; Adams KH; Svarer C; Hasselbalch SG; Holm S; Paulson OB; Knudsen GM
    Biol Psychiatry; 2008 Mar; 63(6):569-76. PubMed ID: 17884017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation and quantification of [18F]altanserin binding in the rat brain using blood input and reference tissue modeling.
    Riss PJ; Hong YT; Williamson D; Caprioli D; Sitnikov S; Ferrari V; Sawiak SJ; Baron JC; Dalley JW; Fryer TD; Aigbirhio FI
    J Cereb Blood Flow Metab; 2011 Dec; 31(12):2334-42. PubMed ID: 21750562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analyses of [(18)F] altanserin bolus injection PET data. I: consideration of radiolabeled metabolites in baboons.
    Price JC; Lopresti BJ; Mason NS; Holt DP; Huang Y; Mathis CA
    Synapse; 2001 Jul; 41(1):1-10. PubMed ID: 11354008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased metabotropic glutamate receptor subtype 5 availability in human brain after one night without sleep.
    Hefti K; Holst SC; Sovago J; Bachmann V; Buck A; Ametamey SM; Scheidegger M; Berthold T; Gomez-Mancilla B; Seifritz E; Landolt HP
    Biol Psychiatry; 2013 Jan; 73(2):161-8. PubMed ID: 22959709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common HTR2A variants and 5-HTTLPR are not associated with human in vivo serotonin 2A receptor levels.
    Spies M; Nasser A; Ozenne B; Jensen PS; Knudsen GM; Fisher PM
    Hum Brain Mapp; 2020 Nov; 41(16):4518-4528. PubMed ID: 32697408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
    Kristiansen H; Elfving B; Plenge P; Pinborg LH; Gillings N; Knudsen GM
    Synapse; 2005 Dec; 58(4):249-57. PubMed ID: 16206185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Equilibrium modeling of 5-HT(2A) receptors with [18F]deuteroaltanserin and PET: feasibility of a constant infusion paradigm.
    van Dyck CH; Soares JC; Tan PZ; Staley JK; Baldwin RM; Amici LA; Fu X; Garg PK; Seibyl JP; Charney DS; Innis RB
    Nucl Med Biol; 2000 Nov; 27(8):715-22. PubMed ID: 11150702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans.
    Price JC; Lopresti BJ; Meltzer CC; Smith GS; Mason NS; Huang Y; Holt DP; Gunn RN; Mathis CA
    Synapse; 2001 Jul; 41(1):11-21. PubMed ID: 11354009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach.
    Haugbøl S; Pinborg LH; Arfan HM; Frøkjaer VM; Madsen J; Dyrby TB; Svarer C; Knudsen GM
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):910-5. PubMed ID: 17195073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognition-induced modulation of serotonin in the orbitofrontal cortex: a controlled cross-over PET study of a delayed match-to-sample task using the 5-HT2a receptor antagonist [18F]altanserin.
    Hautzel H; Müller HW; Herzog H; Grandt R
    Neuroimage; 2011 Oct; 58(3):905-11. PubMed ID: 21722741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Active cyamemazine metabolites in patients treated with cyamemazine (Tercian®): influence on cerebral dopamine D2 and serotonin 5-HT (2A) receptor occupancy as measured by positron emission tomography (PET).
    Hodé Y; Benyamina A; Arbus C; Reimold M
    Psychopharmacology (Berl); 2011 Oct; 217(3):315-21. PubMed ID: 21479533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-HT2A receptor density is decreased in the at-risk mental state.
    Hurlemann R; Matusch A; Kuhn KU; Berning J; Elmenhorst D; Winz O; Kolsch H; Zilles K; Wagner M; Maier W; Bauer A
    Psychopharmacology (Berl); 2008 Jan; 195(4):579-90. PubMed ID: 17899021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced 5-HT(2A) receptor signaling following selective bilateral amygdala damage.
    Hurlemann R; Schlaepfer TE; Matusch A; Reich H; Shah NJ; Zilles K; Maier W; Bauer A
    Soc Cogn Affect Neurosci; 2009 Mar; 4(1):79-84. PubMed ID: 19015089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-efficient and convenient synthesis of [(18)F]altanserin for human PET imaging by a new work-up procedure.
    Massarweh G; Kovacevic M; Rosa-Neto P; Evans AC; Diksic M; Schirrmacher R
    Appl Radiat Isot; 2009 Nov; 67(11):2040-3. PubMed ID: 19692252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous plasma estradiol in healthy men is positively correlated with cerebral cortical serotonin 2A receptor binding.
    Frokjaer VG; Erritzoe D; Juul A; Nielsen FA; Holst K; Svarer C; Madsen J; Paulson OB; Knudsen GM
    Psychoneuroendocrinology; 2010 Oct; 35(9):1311-20. PubMed ID: 20356681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use.
    Erritzoe D; Frokjaer VG; Haugbol S; Marner L; Svarer C; Holst K; Baaré WF; Rasmussen PM; Madsen J; Paulson OB; Knudsen GM
    Neuroimage; 2009 May; 46(1):23-30. PubMed ID: 19457377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of [(18)F]altanserin and [(18)F]deuteroaltanserin for PET imaging of serotonin(2A) receptors in baboon brain: pharmacological studies.
    Staley JK; Van Dyck CH; Tan PZ; Al Tikriti M; Ramsby Q; Klump H; Ng C; Garg P; Soufer R; Baldwin RM; Innis RB
    Nucl Med Biol; 2001 Apr; 28(3):271-9. PubMed ID: 11323237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.